Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT
Status:
NOT_YET_RECRUITING
Trial end date:
2026-05-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the comparative effectiveness of nadroparin versus transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory asymptomatic portal vein thrombosis using a design of a multicenter, randomized controlled trial
Phase:
NA
Details
Lead Sponsor:
Shanghai Zhongshan Hospital
Collaborators:
Renmin Hospital of Wuhan University Shanghai 6th People's Hospital ShuGuang Hospital Tongji Hospital